In this study, we investigated protein levels of galectin-1 in eyes with the different clinical stages of DR, and explored upstream regulatory stimuli for hypoxia-unrelated galectin-1 expression selectively in the pathogenesis of DR but not non-diabetic retinal vascular occlusions. The gene discussed is LGALS1; the disease is retinal vascular occlusion.